Cargando…

Mediation Analysis Reveals Potential Biological Mechanism of Ascites Influencing Recurrence in Patients with Epithelial Ovarian Cancer

OBJECTIVE: Ascites, an accumulation of peritoneal fluid, is associated with poor prognosis of certain cancers. The potential mechanism that ascites worsens prognosis has not been well understood. Lipids have been reported to correlate with the prognosis of patients with epithelial ovarian cancer (EO...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Chunyan, Wang, Ce, Rong, Zhiwei, Xu, Zhenyi, Deng, Kui, Zhao, Weiwei, Cao, Lei, Lu, Yaxin, Adnan, Humara, Li, Kang, Hou, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007789/ https://www.ncbi.nlm.nih.gov/pubmed/32099475 http://dx.doi.org/10.2147/CMAR.S232357

Ejemplares similares

Single-Cell Sequencing of Malignant Ascites Reveals Transcriptomic Remodeling of the Tumor Microenvironment during the Progression of Epithelial Ovarian Cancer
por: Li, Yiqun, et al.
Publicado: (2022)

Improving ovarian cancer treatment decision using a novel risk predictive tool
por: Xu, Zhenyi, et al.
Publicado: (2022)

Proteomics analysis to reveal biological pathways and predictive proteins in the survival of high-grade serous ovarian cancer
por: Xie, Hongyu, et al.
Publicado: (2017)

Clinical and biological effects of tumor associated lymphocytes in the presence or absence of chemotherapy for malignant ascites in ovarian cancer patients
por: Zhang, Weiwei, et al.
Publicado: (2018)

Clinical and biological effects of tumor-associated lymphocytes in the presence or absence of chemotherapy for malignant ascites in ovarian cancer patients
por: Zhang, Weiwei, et al.
Publicado: (2017)

Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma
por: Ho, Chih-Ming, et al.
Publicado: (2012)

Screening and Identification of Biomarkers in Ascites Related to Intrinsic Chemoresistance of Serous Epithelial Ovarian Cancers
por: Huang, He, et al.
Publicado: (2012)

Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer
por: Choi, Jung-A, et al.
Publicado: (2023)

Mirk kinase inhibition targets ovarian cancer ascites
por: Deng, Xiaobing, et al.
Publicado: (2014)

Oncolytic adenovirus inhibits malignant ascites of advanced ovarian cancer by reprogramming the ascitic immune microenvironment
por: Shi, Gang, et al.
Publicado: (2021)

Ascitic complement system in ovarian cancer
por: Bjørge, L, et al.
Publicado: (2005)

The bright side of ascites in ovarian cancer
por: Cohen, Marie, et al.
Publicado: (2014)

Ascites Volumes and the Ovarian Cancer Microenvironment
por: Penet, Marie-France, et al.
Publicado: (2018)

The Epithelial-Mesenchymal Transition Initiated by Malignant Ascites Underlies the Transmesothelial Invasion of Ovarian Cancer Cells
por: Pakuła, Martyna, et al.
Publicado: (2019)

An Obscure Case of Recurrent Ascites and Edema
por: Blumer, George, et al.
Publicado: (1929)

Recurrent abdominal pain and bloody ascites
por: Sung, Chih-Chien, et al.
Publicado: (2011)

Whipple’s Disease Manifested as Recurrent Ascites
por: Aamar, Ali, et al.
Publicado: (2017)

Effect of ovarian cancer ascites on SKOV-3 cells proteome: new proteins associated with aggressive phenotype in epithelial ovarian cancer
por: Toledo-Leyva, Alfredo, et al.
Publicado: (2018)

Treatment of recurrent epithelial ovarian cancer
por: Pisano, Carmela, et al.
Publicado: (2009)

Treatment of Recurrent Epithelial Ovarian Cancer
por: Claussen, Carlota, et al.
Publicado: (2020)

Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review
por: Zhang, Fan, et al.
Publicado: (2017)

Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

The Development of an Angiogenic Protein “Signature” in Ovarian Cancer Ascites as a Tool for Biologic and Prognostic Profiling
por: Trachana, Sofia-Paraskevi, et al.
Publicado: (2016)

HE4 level in ascites may assess the ovarian cancer chemotherapeutic effect
por: Liu, Duanyang, et al.
Publicado: (2018)

Disaggregation and invasion of ovarian carcinoma ascites spheroids
por: Burleson, Kathryn M, et al.
Publicado: (2006)

Deciphering the ovarian cancer ascites fluid peptidome
por: Bery, Anand, et al.
Publicado: (2014)

Chlamydia Peritonitis and Ascites Mimicking Ovarian Cancer
por: Gojayev, Anar, et al.
Publicado: (2016)

Immune Tumor Microenvironment in Ovarian Cancer Ascites
por: Almeida-Nunes, Diana Luísa, et al.
Publicado: (2022)

Erratum: Identification of a six-lncRNA signature associated with recurrence of ovarian cancer
por: Yang, Kai, et al.
Publicado: (2017)

The Prevalence and associated Factors for Liver Metastases, Development and Prognosis in newly diagnosed Epithelial Ovarian Cancer: A large Population-Based Study from the SEER Database
por: Hussain, Iftikhar, et al.
Publicado: (2020)

Afatinib use in recurrent epithelial ovarian carcinoma
por: Shepherd-Littlejohn, Amanda L., et al.
Publicado: (2019)

Exosomes in ovarian cancer ascites promote epithelial–mesenchymal transition of ovarian cancer cells by delivery of miR-6780b-5p
por: Cai, Jing, et al.
Publicado: (2021)

The untapped potential of ascites in ovarian cancer research and treatment
por: Ford, Caroline Elizabeth, et al.
Publicado: (2020)

Hsa_circ_0000497 and hsa_circ_0000918 contributed to peritoneal metastasis of ovarian cancer via ascites
por: Luo, Ning, et al.
Publicado: (2022)

SGLT2 Inhibitors: A New Dawn for Recurrent/Refractory Cirrhotic Ascites
por: Gao, Yuan, et al.
Publicado: (2021)

Intratumoral interleukin-6 predicts ascites formation in patients with epithelial ovarian cancer: A potential tool for close monitoring
por: Masoumi-Moghaddam, Samar, et al.
Publicado: (2015)

Inflammation-regulating factors in ascites as predictive biomarkers of drug resistance and progression-free survival in serous epithelial ovarian cancers
por: Lane, Denis, et al.
Publicado: (2015)

Hemodynamic Consequences of Malignant Ascites in Epithelial Ovarian Cancer Surgery(∗): A Prospective Substudy of a Randomized Controlled Trial
por: Hunsicker, Oliver, et al.
Publicado: (2015)

Effective Treatment for Recurrent Ovarian Cancer Guided by Drug Sensitivity from Ascites-Derived Organoid: A Case Report
por: Chen, Wanyi, et al.
Publicado: (2023)

The detection, treatment, and biology of epithelial ovarian cancer
por: Gubbels, Jennifer AA, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_aearvilqgihq3t4he7kll6652u